Short description
Funxional Therapeutics develops pharmaceutical products focusing on the treatment of various diseases and disorders.
Description
Funxional Therapeutics Ltd. develops pharmaceutical products in the United Kingdom. Its product candidates include BN83470 for the treatment of respiratory indications, initially asthma; BN83250 for the prevention of surgical adhesion formation and for the treatment of stroke; and FX125L, an orally available small molecule that belongs to a therapeutic class named broad spectrum chemokine inhibitors. The company also offers early stage preclinical programs that focus on Alzheimer's disease, autoimmune disorders, and pain and diabetes. Funxional Therapeutics Ltd. as founded in 2005 and is based in Cambridge, the United Kingdom.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Cambridge, Cambridgeshire, United Kingdom, Europe
Founded on
January 1, 2005
Closed on
July 1, 2012
Exited on
July 1, 2012
Non-profit?
No
Acquired?
No
Employees count
11-50
Investors
No Way, Noaccess, Cannot Access
Sign in for full access
Founders
Bob Schroff, Callum Campbell, David Grainger, Jason Avery